Biotech

All Articles

Lilly- backed fat loss biotech data IPO

.After elevating $170 thousand back in February, metabolic disease-focused BioAge Labs has actually ...

Aelis' marijuana usage drug fails period 2b, steering Indivior to re-think $100M option

.Aelis Farma's chances of safeguarding a quick, positive choice on a $100 thousand choice remittance...

ProKidney stops phase 3 test certainly not needed to have for tissue treatment authorization

.ProKidney has actually quit some of a set of period 3 trials for its tissue therapy for kidney ailm...

Vaxcyte rises on 'spectacular' 31-valent PCV gain against Pfizer

.Vaxcyte introduced what experts called "impressive" period 1/2 information for its 31-valent pneumo...

Recursion's human brain illness test shows little proof of efficacy

.Recursion has actually stumbled via a very early test of its tech-enabled technique to medication d...

Acepodia, Pfizer click on all together for chemistry-based tissue therapy

.Contact it an instance of excellent chemical make up: Acepodia, a biotech based upon Nobel Prize-wi...

Praxis epilepsy drug lessens seizures in phase 2 hearing

.Praxis Preciseness Medicines has actually racked up one more midphase win in epilepsy this year, al...

Three execs surrender as Dyne blog posts mixed information for DMD candidate

.After escaping a clinical grip several years back, Dyne Therapy has uncovered brand new stage 1/2 r...

Arrowhead fires off phase 3 data in rare metabolic illness in advance of market clash with Ionis

.Arrowhead Pharmaceuticals has actually presented its give before a potential face-off along with Io...

Pfizer, Valneva reveal lyme disease shot effective for second booster

.Pfizer as well as Valneva may possess about pair of more years to stand by prior to they help make ...